Date: Sunday, November 8, 2015
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
To evaluate the association between smoking and cognitive function in patients with fibromyalgia (FM).
We surveyed 668 patients with FM from May 2012 through November 2013. Patients were categorized by smoking status (non-smoker and smoker). Primary outcomes included cognitive symptoms (MASQ). Secondary outcomes include fatigue (MFI-20), sleep (MOS-sleep Scale), depression (PHQ-9), anxiety (GAD-7), overall FM symptom severity (FIQ-R), and quality of life (SF-36). Univariate and multivariate analyses were used.
Ninety-four (14.07%) patients self-identified as smokers. Smokers were associated with several demographic variables, including lower education, unmarried status, and younger age. Smokers reported worse cognitive functions, including total functional score and 4 out of 5 domains of the MASQ (all p<0.05) Secondary outcomes showed worse sleep (MOS-sleep scale p=0.01), anxiety (GAD-7 total p=0.001), depression (PHQ-9 p=0.04), FM symptom severity (FIQ-R total score p<0.01), and QoL in bodily pain(BP) and mental health(MCS) (SF-36: BP p=0.03; MCS p=0.02).
The results of this study indicate that smokers with FM report worse cognitive function. Although the cause-effect relationship between smoking and cognition is unclear, clinicians who care for patients with FM should be aware of this association.
To cite this abstract in AMA style:Ge L, Oh TH, Vincent A, Mohabbat A, Jiang L, Whipple M, McAllister S, Wang Z, Qu W. Association of Smoking and Cognitive Function in Patients with Fibromyalgia [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/association-of-smoking-and-cognitive-function-in-patients-with-fibromyalgia/. Accessed September 22, 2018.
« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-smoking-and-cognitive-function-in-patients-with-fibromyalgia/